InsiderTrades

Form 4/A for EMBC Embecta Corp.

Accepted 2022-05-12 00:00:00 ET · period of report 2022-04-01 · accession 0001209191-22-028635 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DA 2022-05-12 2022-04-04 EMBC Mann Jeffrey Z SVP, GC, Head Corp. Dev, Secy A - Grant $0.00 +17.8K 32.4K +122% $0
DA 2022-05-12 2022-04-01 EMBC Mann Jeffrey Z SVP, GC, Head Corp. Dev, Secy J - Other $0.00 +104.2K 104.2K New $0
DA 2022-05-12 2022-04-04 EMBC Mann Jeffrey Z SVP, GC, Head Corp. Dev, Secy A - Grant $0.00 +54.5K 158.6K +52% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-04-04 A A 17,813 $0.00 32,390 D — — (F1) This Form 4 is being amended to reflect a recalculation of the Time Vested Units ("TVUs") that the reporting person received on April 4, 2022 in connection with Embecta's spinoff from Becton, Dickinson and Company ("BD") on April 1, 2022. (F2) This Form 4 now includes 14,577 TVUs that were received by the reporting person when he was employed by BD, which were later converted to Embecta TVUs in connection with Embecta's spinoff from BD on April 1, 2022.
2 Derivative Stock Appreciation Rights 2022-04-01 J A 104,150 $0.00 104,150 D $28.31 · 2022-11-26 to 2031-11-26 104,150 Common Stock (F3) This Form 4 now includes Stock Appreciation Rights ("SARs") that were received by the reporting person when he was employed by BD, which were later converted to Embecta SARs in connection with Embecta's spinoff from BD on April 1, 2022. (F4) The SARs vest in four annual installments beginning November 26, 2022.
3 Derivative Stock Appreciation Rights 2022-04-04 A A 54,450 $0.00 158,600 D $31.40 · 2025-04-04 to 2032-04-04 54,450 Common Stock (F5) This Form 4 is being amended to reflect a recalculation of the SARs that the reporting person received on April 4, 2022 in connection with Embecta's spinoff from BD.